1. Research Framework
1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation
2. Executive Summary
3. India In-Vitro Diagnostics (IVD) Market Insights
3.1. Industry Value Chain Analysis
3.2. DROC Analysis
3.2.1. Growth Drivers
3.2.1.1. Increasing prevalence of chronic diseases
3.2.1.2. Innovations in IVD technology, such as point-of-care testing, molecular diagnostics, and automation
3.2.1.3. Rising healthcare expenditure
3.2.1.4. Growing awareness about early disease detection
3.2.2. Restraints
3.2.2.1. Unfavorable reimbursement scenario
3.2.2.2. High cost of development
3.2.2.3. Stringent regulatory environment
3.2.3. Opportunities
3.2.3.1. Emerging technologies such as liquid biopsy, digital pathology, and microfluidics
3.2.3.2. Increasing adoption of personalized medicine
3.2.3.3. Growing demand for rapid and accessible diagnostic solutions
3.2.4. Challenges
3.2.4.1. Shortage of skilled professionals in the IVD industry
3.2.4.2. Increasing concerns about data privacy and security
3.3. Technological Advancements/Recent Developments
3.4. Regulatory Framework
3.5. Porter's Five Forces Analysis
3.5.1. Bargaining Power of Suppliers
3.5.2. Bargaining Power of Buyers
3.5.3. Threat of New Entrants
3.5.4. Threat of Substitutes
3.5.5. Intensity of Rivalry
4. India In-Vitro Diagnostics (IVD) Market Marketing Strategies
5. India In-Vitro Diagnostics (IVD) Market Overview
5.1. Market Size & Forecast, 2019-2030
5.1.1. By Value (USD Billion)
5.2. Market Share & Forecast
5.2.1. By Product and Services
5.2.1.1. Reagents and Kits
5.2.1.2. Instruments
5.2.1.3. Software and Services
5.2.2. By Technique
5.2.2.1. Molecular Diagnostics
5.2.2.2. Tissue Diagnostics
5.2.2.3. Clinical Chemistry
5.2.2.4. Immunodiagnostics
5.2.2.5. Hematology
5.2.3. By Application
5.2.3.1. Infectious Diseases
5.2.3.2. Cancer
5.2.3.3. Cardiac Diseases
5.2.3.4. Immune System Disorders
5.2.3.5. Nephrological Diseases
5.2.3.6. Gastrointestinal Diseases
5.2.3.7. Others
5.2.4. By End User
5.2.4.1. Standalone Laboratories
5.2.4.2. Hospitals
5.2.4.3. Academic and Medical Schools
5.2.4.4. Point of Care
5.2.4.5. Others
5.2.5. By Region
5.2.5.1. North India
5.2.5.2. South India
5.2.5.3. East India
5.2.5.4. West India
6. North India In-Vitro Diagnostics (IVD) Market
6.1. Market Size & Forecast, 2019-2030
6.1.1. By Value (USD Billion)
6.2. Market Share & Forecast
6.2.1. By Product and Services
6.2.2. By Technique
6.2.3. By Application
6.2.4. By End User
7. South India In-Vitro Diagnostics (IVD) Market
7.1. Market Size & Forecast, 2019-2030
7.1.1. By Value (USD Billion)
7.2. Market Share & Forecast
7.2.1. By Product and Services
7.2.2. By Technique
7.2.3. By Application
7.2.4. By End User
8. East India In-Vitro Diagnostics (IVD) Market
8.1. Market Size & Forecast, 2019-2030
8.1.1. By Value (USD Billion)
8.2. Market Share & Forecast
8.2.1. By Product and Services
8.2.2. By Technique
8.2.3. By Application
8.2.4. By End User
9. West India In-Vitro Diagnostics (IVD) Market
9.1. Market Size & Forecast, 2019-2030
9.1.1. By Value (USD Billion)
9.2. Market Share & Forecast
9.2.1. By Product and Services
9.2.2. By Technique
9.2.3. By Application
9.2.4. By End User
10. Competitive Landscape
10.1. List of Key Players and Their Offerings
10.2. India In-Vitro Diagnostics (IVD) Company Market Share Analysis, 2023
10.3. Competitive Benchmarking, By Operating Parameters
10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
11. Impact of Escalating Geopolitical Tensions on India In-Vitro Diagnostics (IVD) Market
12. Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)
12.1. Roche Diagnostic
12.2. Abbott Laboratories
12.3. Beckman Coulter
12.4. Becton and Dickinson
12.5. Sysmex
12.6. Transasia Bio-Medicals Ltd
12.7. Thermo Fisher Scientific Inc
12.8. J Mitra & Co Pvt Ltd
12.9. Advatech Healthcare Pvt Ltd
12.10. Tulip Diagnostics Pvt. Ltd.
12.11. Siemens Healthcare Pvt. Ltd.
12.12. Bio-Rad Laboratories India Pvt. Ltd
12.13. Other Prominent Players
13. Key Strategic Recommendations
14. Research Methodology
14.1. Qualitative Research
14.1.1. Primary & Secondary Research
14.2. Quantitative Research
14.3. Market Breakdown & Data Triangulation
14.3.1. Secondary Research
14.3.2. Primary Research
14.4. Breakdown of Primary Research Respondents, By Region
14.5. Assumptions & Limitations
*Financial information of non-listed companies can be provided as per availability.
**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable.